Sunshine Biopharma, Inc.
SBFM
$1.55
-$0.04-2.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.40% | -20.65% | 6.07% | -33.99% | 7.01% |
| Total Receivables | -10.94% | 20.19% | -19.00% | 40.52% | 10.79% |
| Inventory | 5.13% | 14.84% | 15.66% | 10.30% | 34.23% |
| Prepaid Expenses | -13.22% | 54.02% | -58.58% | 103.87% | 180.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -5.72% | -0.06% | 0.91% | -10.69% | 15.83% |
|
|
|||||
| Total Current Assets | -5.72% | -0.06% | 0.91% | -10.69% | 15.83% |
| Net Property, Plant & Equipment | -4.14% | 30.89% | 2.44% | 10.32% | -1.06% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.75% | 2.62% | 20.25% | 18.47% | 43.02% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -- | -- | -- | -- |
| Total Assets | -4.49% | 1.68% | 2.58% | -8.14% | 16.64% |
|
|
|||||
| Total Accounts Payable | -9.36% | 33.33% | -15.68% | 36.37% | 39.83% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.98% | 78.68% | 1.57% | -0.78% | -2.78% |
| Total Finance Division Other Current Liabilities | -7.13% | 121.22% | 0.00% | -90.90% | -1.58% |
| Total Other Current Liabilities | -7.13% | 121.22% | 0.00% | -90.90% | -1.58% |
| Total Current Liabilities | -8.75% | 39.45% | -14.55% | -18.89% | 17.68% |
|
|
|||||
| Total Current Liabilities | -8.75% | 39.45% | -14.55% | -18.89% | 17.68% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.02% | 69.13% | -4.88% | -6.86% | -7.79% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Liabilities | -8.14% | 40.70% | -13.66% | -17.91% | 15.30% |
|
|
|||||
| Common Stock & APIC | 0.38% | 1.76% | 2.11% | 0.00% | 6.43% |
| Retained Earnings | -1.71% | -3.23% | -1.82% | -0.76% | -2.01% |
| Treasury Stock & Other | 3.16% | -592.29% | 124.68% | -548.23% | -78.11% |
| Total Common Equity | -3.40% | -6.15% | 6.60% | -5.36% | 16.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 0.00% | 0.00% | 0.00% | 0.00% | 1,200.00% |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 1,200.00% |
|
|
|||||
| Total Common Equity | -3.40% | -6.15% | 6.60% | -5.36% | 16.98% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 1,200.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.40% | -6.14% | 6.60% | -5.36% | 17.03% |
|
|
|||||